Chronic Obstructive Lung Disease Clinical Trial
Official title:
Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD
Verified date | June 2015 |
Source | Klinikum Berchtesgadener Land der Schön-Kliniken |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Interventional |
All measurements are performed on two consecutive days at the beginning of a pulmonary
rehabilitation program in a randomized cross-over study design. On the first day, each
patient is randomly assigned to perform either the 2 minute walk test or the 6 Minute walk
test. On the second day each patient performs the test that was not performed on the first
day. All walk tests are performed by the same investigator on the same track and time of
day, following the 2002 guidelines of the American Thoracic Society.
Patients wear a mobile pulse oximeter that continuously records heart rate and oxygen
saturation during testing. Baseline values of oxygen saturation, heart rate and ratings of
perceived exertion on the modified Borg scale (0 to 10) for dyspnea and leg fatigue are
recorded at rest after 10 minutes of sitting.
Status | Completed |
Enrollment | 26 |
Est. completion date | August 2007 |
Est. primary completion date | May 2007 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - confirmed diagnosis of chronic obstructive lung disease stage III or IV according to the Global Initiative for chronic Obstructive Lung Diseases definition - ability to read and understand the German language and study procedures. - written informed consent Exclusion Criteria: - severe acute exacerbation of chronic obstructive lung disease - severe respiratory failure (partial Oxygen pressure at rest lower than 55 millimeter mercury) - non compliance to the study protocol. |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Klinikum Berchtesgadener Land der Schön-Kliniken |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | oxygen desaturation | up to 6 minute walk test | Yes | |
Secondary | heart rate | during 2 minute walk test and 6 minute walk test | No | |
Secondary | perceived exertion for dyspnea and leg fatigue | measured by a modified Borg scale from 0 to 10 | during 2 minute walk test and 6 minute walk test | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01416701 -
Vitamin D and Chronic Obstructive Lung Disease
|
Phase 4 | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT00202150 -
Primary Care Management/Action Plans for Advanced Chronic Diseases
|
Phase 2/Phase 3 | |
Recruiting |
NCT05227547 -
Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
|
N/A | |
Withdrawn |
NCT02273349 -
Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
|
N/A | |
Completed |
NCT00018408 -
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
Completed |
NCT02987439 -
COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD
|
N/A | |
Completed |
NCT01950936 -
Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD)
|
Phase 2/Phase 3 | |
Completed |
NCT01404000 -
Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal
|
Phase 2 | |
Terminated |
NCT03811158 -
The Edi Level and Cardiopulmonary Function Between HHHFNC and Unheated Humidified High-Flow Oxygen Mask in COPD
|
N/A | |
Recruiting |
NCT01631162 -
The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples
|
N/A | |
Completed |
NCT01596023 -
Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients
|
N/A | |
Completed |
NCT01347931 -
In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency
|
N/A | |
Terminated |
NCT01712854 -
Effects of Symbicort on the Ventilatory Kinematics
|
Phase 4 | |
Recruiting |
NCT06090149 -
Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients
|
N/A | |
Recruiting |
NCT02778802 -
Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR
|
N/A | |
Enrolling by invitation |
NCT02278107 -
Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease
|
N/A | |
Completed |
NCT01614951 -
The Pulmonary Protection Trial
|
Phase 4 | |
Completed |
NCT01787097 -
Effect of Symbicort ® on GR in Sputum in COPD
|
Phase 4 | |
Completed |
NCT01495780 -
eRT Remote Health Monitoring
|
N/A |